Innocan Pharma Reports Q2 2023 Results Including US$2.706M Increase in Revenues Compared to Q2, 2022

/PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan"), a pharmaceutical technology company focusing on...

Related Keywords

Israel ,Canada ,Herzliya ,Tel Aviv ,Canadian ,Iris Bincovich ,Bi Sky Global Ltd ,Innocan Pharma Corporation ,Prnewswire Innocan Pharma Corporation ,Company Or Innocan ,Gross Profit ,Pharma Corporation ,Global Ltd ,Chronic Pain Management ,Central Nervous System ,Consumer Wellness ,Joint Venture ,